Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Retatrutide Structure and Chemistry Retatrutide builds on the engineering principles refined in semaglutide and tirzepatide: Glucagon-based peptide backbone retatrutide is derived from glucagon, with modifications to give it activity at all three target receptors Strategic amino acid substitutions multiple substitutions tune the receptor activity balance across GLP-1R, GIPR, and glucagon receptor Fatty acid chain attached for albumin binding and extended half-life (similar strategy to semaglutide and tirzepatide) Aminoisobutyric acid substitutions protect against DPP-4 enzymatic degradation The triple-agonist design is technically demanding because each receptor has different binding requirements
GLP-1 agonists often continue indefinitely for weight maintenance, while GH secretagogues may cycle with periodic breaks
operate in a unique niche within the market for weight loss drugs
preserves NAD+ salvage and SAM availability Regulatory status: not approved by the FDA or any other regulatory authority
It appears that LC supplementation, through reducing weight, improving sex hormone levels, and enhancing ovarian structure, may offer a promising approach for alleviating complications associated with PCOS and reducing other related disorders
